University of Notre Dame du Lac’s Abiomed Inc ABMD Stock Holding History

University of Notre Dame du Lac’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-7,216	Closed	-$2.06M	–	74
2019 Q1	$2.06M	Sell	7,216 -460	-6%	-$153K	0.46%	60
2018 Q4	$2.5M	Buy	7,676 +190	+3%	+$66K	0.6%	47
2018 Q3	$3.37M	Buy	7,486 +259	+4%	+$102K	0.63%	46
2018 Q2	$2.96M	Sell	7,227 -3,226	-31%	-$1.17M	0.57%	53
2018 Q1	$3.04M	Sell	10,453 -3,063	-23%	-$776K	0.57%	58
2017 Q4	$2.53M	Sell	13,516 -2,951	-18%	-$551K	0.53%	64
2017 Q3	$2.78M	Sell	16,467 -1,888	-10%	-$285K	0.77%	58
2017 Q2	$2.63M	Sell	18,355 -2,473	-12%	-$332K	0.78%	59
2017 Q1	$2.61M	Buy	+20,828	New	+$2.41M	0.65%	55

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

University of Notre Dame du Lac's ABMD Position: Q2 2019 in Review

University of Notre Dame du Lac sold out of Abiomed Inc (ABMD) in Q2 2019, closing a stake of 7,216 shares — an estimated $2.06M sold.

University of Notre Dame du Lac first reported a position in ABMD in Q1 2017 and held it in 9 quarters. The position peaked at $3.37M in Q3 2018. 484 funds tracked by Wall St. Rank hold ABMD as of Q2 2019.

University of Notre Dame du Lac reported no remaining Abiomed Inc position as of Q2 2019 after selling out during the quarter.
University of Notre Dame du Lac sold 7,216 Abiomed Inc shares in Q2 2019, an estimated $2.06M.
University of Notre Dame du Lac first reported a position in Abiomed Inc in Q1 2017 and held it in 9 quarters.
University of Notre Dame du Lac's Abiomed Inc position peaked at $3.37M in Q3 2018.
484 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2019.

Based on University of Notre Dame du Lac's 13F filing for Q2 2019, filed 14 Aug 2019.